Results of International, Double-Blind, Randomized, Placebo-Controlled, Phase IIa Study of Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment-Elevation Myocardial Infarction (STEMI).
Antonio AbbateBenjamin W Van TassellVlad BoginRoshanak MarkleyDmitry V PevznerPaul C CremerImad MerayDmitry V PrivalovAngela TaylorSergey A GrishinAlina N EgorovaEkaterina G PonomarYan LavrovskyMikhail Yu Samsonovnull nullPublished in: Circulation (2024)
Keyphrases
- placebo controlled
- double blind
- st segment elevation myocardial infarction
- percutaneous coronary intervention
- phase iii
- clinical trial
- phase ii
- study protocol
- st elevation myocardial infarction
- phase ii study
- acute coronary syndrome
- coronary artery disease
- randomized controlled trial
- open label
- squamous cell carcinoma
- atrial fibrillation